Marijn van der Wal of Bird & Bird says a landmark Unified Patent Court case highlights the potential of expert witnesses to ...

DexCom Inc. closed 39.13% short of its 52-week high of $142.00, which the company achieved on March 26th.

Geneos Wealth Management Inc. lessened its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 2.6% in the ...

This study reinforces the significance of intensive glycaemic control and is a paradigm shift in managing the disease and its complications.

Fifth Third Bancorp grew its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 21.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm ...

Shares of DexCom Inc. DXCM slid 1.37% to $87.53 Monday, on what proved to be an all-around mixed trading session for the ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...